
|Articles|August 28, 2015
New Actos Trial Begins in Las Vegas
August 28, 2015.
Advertisement
Takeda's Actos went on trial in Las Vegas, NV again yesterday, having been cleared last year of causing bladder cancer in two Nevada women. This time attorneys from law firms Eglet Prince and Kemp, Jones & Coulthard are arguing that Maurice J. Iorio (deceased) and Geroge Decou suffered severe effects after using the diabetes drug. Iorio died from bladder cancer complications in November 2013 and Decou is currently suffering from bladder cancer. The stakes are high for the Japanese-headquartered company; last year a Louisiana jury awarded a $9 bn verdict in an Actos trial. Currently, Takeda is looking to establish a settlement with an estimated 8000 US plaintiffs who believe Actos caused their bladder cancer.
Advertisement
Advertisement
Advertisement
Trending on PharmExec
1
FDA Makes Leadership Overhaul Following Commissioner Makary’s Departure: Report
2
Pharma Roundup: Bristol Myers Squibb Enters Strategic Agreement with Anthropic, Incyte and Genesis Expand Strategic Collaboration
3
Eli Lilly Enters $202 Million Agreement to Acquire Engage Bio
4
Pharma Funding Roundup: Violet Therapeutics' $4.75 Million Seed Extension Financing, Full-Life Technologies Completes $150 Million Financing
5




